GLP-1 medications
The medications we prescribe
Omnia Health prescribes only branded, FDA-approved GLP-1 medications, never compounded versions. Which one fits you depends on your diagnosis, your coverage and how you respond, decided with a physician. Here is each medication we offer, including both once-daily pills: orforglipron (Foundayo) and Wegovy tablets.
Medically reviewed by Dr. Roger Eduardo, MD, FASMBS, Board-Certified General Surgeon. Last reviewed August 2026.
Book a consultation →Semaglutide
Wegovy · Ozempic · oral tablet
One molecule, several names. FDA-approved for chronic weight management (Wegovy) and type 2 diabetes (Ozempic), plus a daily oral tablet.
Once-weekly injection, or once-daily oral tablet
Learn more →Tirzepatide
Zepbound · Mounjaro
One molecule, two names. Dual GIP/GLP-1, FDA-approved for chronic weight management (Zepbound) and type 2 diabetes (Mounjaro).
Once-weekly injection, prefilled pen
Learn more →Orforglipron (Foundayo)
Oral GLP-1 pill
A once-daily GLP-1 pill, FDA-approved April 2026 for weight loss. The only one with no rules attached: any time of day, with or without food.
Once-daily oral tablet
Learn more →Wegovy tablets
Oral semaglutide 25 mg
The Wegovy molecule in a daily pill, FDA-approved December 2025. Results close to the injection, but it has to be taken on an empty stomach.
Once-daily oral tablet
Learn more →Pills and injections both
Which one is right is a medical question, not a menu choice
Your diagnosis, your coverage, your tolerance for needles and your morning routine all change the answer. Dr. Eduardo makes a recommendation, and explains why.
Not sure which?
Compare them side by side
Start your journey
Which medication is right for you?
Book a consultation with Dr. Eduardo. We match the medication to your diagnosis, coverage and goals, never one-size-fits-all.
